Category Archives: Public Policy

Latest From Public Policy

Burrill Report Podcast: Implications of Gene Patent Ruling

The Burrill Report podcast on the impact of the recent decision invalidating patents on genetic materials.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , ,

From Lab to Commercialization: NIH Licenses Offer Another Path

If a biomedical breakthrough occurs within a federal lab, chances are your company can license use of the technology from the National Institutes of Health’s Office of Technology Transfer (OTT).

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , ,

Tomorrow: BIO is “To the Point” on Gene Patenting

BIO is participating in an NPR segment at approximately 2:08pm ET tomorrow on the nationally-syndicated national radio program “To the Point” which originates in NYC. It should air on WAMU in DC, too, for those of you in the Nation’s capital.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: ,

FluGen: Tech Transfer in the Madison, Wisconsin Region

FluGen is a strong case study in not only top leading research happening at the UW Madison, but also of how the infrastructure of the region helps this R&D spinout into productive, leading global businesses that help heal, feed and fuel the world.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,

Wisconsin Institutes for Discovery: Changing ‘Humankind’

The Wisconsin Institutes for Discovery facility is possibly the most-watched building project in the Madison Region today, and is designed with a vision “to change the state of humankind.”

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: ,